[1]
D. R. Edla, H. Pasupulati, and S. SV Padi, “Spesolimab: A Novel Interleukin-36 Receptor Monoclonal Antibody for the Treatment of Generalized Pustular Psoriasis”, Asian J Pharm Res Dev, vol. 12, no. 3, pp. 88–93, Jun. 2024.